新诺威:业绩、资本与人事的三重考验

新浪财经
11 Apr

导读: 石药集团 一系列资本运作虽曾推动股价飙升,却在业绩下滑后面临重重考验。近日,石药创新制药股份有限公司(股票简称: 新诺威 )发布了2024年年报。2024年实现营业收入19.81亿元,同比减少21.98%;实现归母净利润5372.63万元,同比减少87.63%;实现扣非净利润4234.19万元,同比减少94.31%。在 医药行业 风云变幻的浪潮中,新诺威这家曾经的市场宠儿正深陷多重困境。...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10